Natera, Inc.: Initiation Of Coverage – Can It Successfully Leverage The Invitae Acquisition? 

Natera, Inc.’s latest quarterly earnings reveal positive growth prospects and the firm’s commitment to maintaining momentum in their healthcare ventures. The company saw a rise in revenue, reaching $311 million for Q4, a substantial growth of 43% over the same period in 2022. Furthermore, its full-year revenues were reported at $1.08 billion, up by more than 30% compared to the previous year. These results come on the back of the company processing a significantly higher number of tests in 2023, suggesting a strong demand for the company’s services.